Peritoneal dialysis

The beginnings of haemodialysis have been described many times, but the first successful peritoneal dialysis probably antedated the first successful haemodialysis by 7 years. Peritoneal dialysis was undertaken alongside haemodialysis in most renal units from the early 1960s, but also in many hospitals without renal units, and numbers are poorly recorded.

In the article, Urgent Start Peritoneal Dialysis: A Chance for a New Beginning, the authors suggests a paradigm shift from our conventional algorithm of renal replacement therapy. They bring to the forefront the concept of urgent start peritoneal dialysis. This concept addresses the challenges of the late referral or urgent dialysis initiation. These patients are an unfortunate reality for the nephrology community.

The impact of dialysis modality survival is still somewhat controversial because there are conflicting research results about the survival differences between Peritoneal Dialysis (PD) and Hemodialysis (HD), especially during the first 2 years of dialysis treatment. The survival discrepancies among Chronic Kidney Disease (CKD) patients using different dialysis modalities is hard to pin-down because of differential rates of modality switching, varying rates of Kidney Transplantation, and possible differences in patients’ personal characteristics leading to death. 

Peritoneal dialysis is one of the treatment options for person suffering from end stage renal disease. It is a form of dialysis wherein the patient enjoys the benefit of the dialysis in the comfort of his home. Let is learn in detail about peritoneal dialysis.

During the last three years, Chance Smiling has made peace with the task master in his life. After receiving hemodialysis, a process that filters blood, for about six years in a clinical setting, he started doing peritoneal dialysis at home.

Baxter International Inc. (BAX - Analyst Report) recalled a single lot of Dianeal PD-2 peritoneal dialysis solution with 1.5% dextrose 6000 mL (Ambu-Flex II) after receiving reports about the presence of a particulate matter, known as mold, resulting from a leak in the container. The news had a negative reaction on the market as shares of the company slid 0.5% to close at $67.57 yesterday. Contamination of a solution with mold could lead to life-threatening fungal peritoneal infection or sepsis upon its intraperitoneal (IP) administration. The affected lot is C903799, with expiration date of May 2015, product code of L5B9710, and national drug code of 00941-0411-11.

Baxter International has recalled one lot of DIANEAL PD-2 Peritoneal Dialysis Solution after receiving customer complaints of particulate matter, confirmed as mold.

Peritoneal dialysis solution is injected directly into a patient’s body cavity (peritoneum). Moldy products could potentially cause a life-threatening fungal peritoneal infection (fungal peritonitis) or sepsis (blood poisoning). Baxter has received reports of adverse events but “no causal relationship has been established.”

Baxter International Inc. announced today it has initiated a voluntary recall in the United States of a single lot of DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose 6000mL (Ambu-Flex II) to the hospital/user level. The recall is being initiated as a result of complaints of particulate matter, identified as mold, resulting from a leak in the container.

Mangalore, Mar 3, 2014: State’s first ever Peritoneal Dialysis centre in a government hospital was inaugurated on Sunday by Minister for Health and Family welfare U T Khader at Wenlock District Hospital in Mangalore.

Dialysis cleanses the body of waste products in the body by use of filter systems. There are two types of dialysis; 1) hemodialysis, and 2) peritoneal dialysis.
Hemodialysis uses a machine filter called a dialyzer or artificial kidney to remove excess water and salt, to balance the other electrolytes in the body, and to remove waste products of metabolism. Blood is removed from the body and flows through tubing into the machine, where it passes next to a filter membrane.
Peritoneal dialysis in renal failure treatment that utilizes the peritoneal membrane to filter out the blood of individuals who have renal disease.

Peritoneal dialysis (PD) is a dialysis treatment that is used as an alternative to haemodialysis (HD) for patients with severe kidney disease. In peritoneal dialysis, the patient’s peritoneum which is located in the abdomen acts as a membrane which filters out fluids and other dissolved substances from the blood. The waste products from the patient’s body are flushed out either every night while the patient sleeps (automatic peritoneal dialysis) or via regular exchanges throughout the day (continuous ambulatory peritoneal dialysis).